Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Board Committee Changes

29 Jul 2016 16:45

RNS Number : 7403F
Reckitt Benckiser Group PLC
29 July 2016
 

29 July 2016

RECKITT BENCKISER GROUP PLC

(The "Company" or "RB")

 

BOARD COMMITTEE CHANGES

 

The Company is pleased to announce the following changes to its standing Board Committees and their membership.

New Corporate Responsibility, Sustainability, Ethics and Compliance Committee

On the recommendation of the Nomination Committee, on 28 July 2016 the Board approved the establishment of a new Board committee to be known as the Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSEC Committee") with immediate effect. This new committee will support the Board in fulfilling its duty to safeguard and advance the Company's reputation for responsible and sustainable corporate conduct by reviewing, monitoring and assessing its approach to and management of corporate social responsibility, environmental and sustainability issues and behaviours, ethical conduct and regulatory compliance.

The CRSEC Committee will be chaired by Pam Kirby, and Adrian Bellamy and Nicandro Durante have been appointed as committee members. The CRSEC Committee will meet at least three times per year and at such other times as required. 

The Committee's terms of reference will be available on the Company's website at www.rb.com

Nomination Committee Membership

The Nomination Committee also recommended, and the Board approved, the appointment of Pam Kirby to the Nomination Committee with immediate effect. 

This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.

 

For further Information:

Chris LoganCompany Secretary+44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

+44 (0)1753 217 800

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

 

For more information visit www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEEFIUFMSELW
Date   Source Headline
21st Mar 20172:00 pmRNSDirectorate Change
20th Mar 20173:30 pmRNSDirector/PDMR Shareholding
17th Mar 201711:57 amRNSDirector/PDMR Shareholding
1st Mar 201711:36 amRNSTotal Voting Rights
28th Feb 20175:00 pmRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSRB to acquire Mead Johnson
10th Feb 20177:00 amRNSFull Year Results 2016
2nd Feb 20177:00 amRNSStatement regarding Mead Johnson
1st Feb 201710:07 amRNSTotal Voting Rights
3rd Jan 20179:00 amRNSTotal Voting Rights
5th Dec 20167:00 amRNSTransaction in Own Shares
2nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20167:00 amRNSTransaction in Own Shares
1st Dec 20169:45 amRNSTotal Voting Rights
1st Dec 20167:00 amRNSTransaction in Own Shares
30th Nov 20167:00 amRNSTransaction in Own Shares
29th Nov 20167:00 amRNSTransaction in Own Shares
28th Nov 20167:00 amRNSTransaction in Own Shares
25th Nov 20167:00 amRNSTransaction in Own Shares
24th Nov 20167:00 amRNSTransaction in Own Shares
23rd Nov 20167:00 amRNSTransaction in Own Shares
22nd Nov 20167:00 amRNSTransaction in Own Shares
21st Nov 20167:00 amRNSTransaction in Own Shares
18th Nov 20167:00 amRNSTransaction in Own Shares
17th Nov 20167:00 amRNSTransaction in Own Shares
16th Nov 20165:21 pmRNSTransaction in Own Shares - replacement
16th Nov 20167:00 amRNSTransaction in Own Shares
15th Nov 20167:00 amRNSTransaction in Own Shares
14th Nov 20167:00 amRNSTransaction in Own Shares
11th Nov 20167:00 amRNSTransaction in Own Shares
10th Nov 20167:00 amRNSTransaction in Own Shares
9th Nov 20167:00 amRNSTransaction in Own Shares
8th Nov 20167:00 amRNSTransaction in Own Shares
7th Nov 20162:36 pmRNSDirector/PDMR Shareholding
7th Nov 20167:00 amRNSTransaction in Own Shares
4th Nov 20167:00 amRNSTransaction in Own Shares
3rd Nov 20167:00 amRNSTransaction in Own Shares
2nd Nov 20167:00 amRNSTransaction in Own Shares
1st Nov 20169:21 amRNSTotal Voting Rights
1st Nov 20167:00 amRNSTransaction in Own Shares
31st Oct 20167:00 amRNSTransaction in Own Shares
28th Oct 20167:00 amRNSTransaction in Own Shares
27th Oct 20167:00 amRNSTransaction in Own Shares
26th Oct 20167:00 amRNSTransaction in Own Shares
25th Oct 20165:15 pmRNSDirector/PDMR Shareholding
25th Oct 20167:00 amRNSTransaction in Own Shares
24th Oct 20167:00 amRNSTransaction in Own Shares
21st Oct 20164:54 pmRNSDirector/PDMR Shareholding
20th Oct 20164:46 pmRNSShare Repurchase Programme
19th Oct 20167:00 amRNSQ3 2016 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.